August 1, 2025: Study Finds that Ozempic May Cause Hair Loss, Especially in Women A preliminary study suggests that Ozempic may increase the risk of hair loss in some patients
Building an indication-aware PA infrastructure lays the workflow foundation for whatever comes next in GLP-1 coverage, including the possibility that Part D plans eventually take on broader obesity drug coverage as policy continues to evolve
RDs typically help patients on GLP-1 medications focus on eating adequate protein, fiber, and micronutrients to prevent malnutrition and muscle loss
Using generalized mixed models, test results were compared to expected disease progression based on historical data
from $79 A Personalized Approach to Semaglutide Weight Loss in Buffalo Semaglutide may be recommended for eligible adults seeking physician-guided support for obesity, weight-related health conditions, or long-term weight management